Perturbation of Cytochrome c Maturation Reveals Adaptability of the Respiratory Chain in Mycobacterium tuberculosis by Small, Jennifer L. et al.
Perturbation of Cytochrome c Maturation Reveals Adaptability of the
Respiratory Chain in Mycobacterium tuberculosis
Jennifer L. Small,a Sae Woong Park,a Bavesh D. Kana,b Thomas R. Ioerger,c James C. Sacchettini,c Sabine Ehrta
Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York, USAa; DST/NRF Centre of Excellence for Biomedical TB Research,
Faculty of Health Sciences, University of the Witwatersrand and the National Health Laboratory Service, Johannesburg, South Africab; Department of Biochemistry and
Biophysics, Texas A&M University, College Station, Texas, USAc
ABSTRACT Mycobacterium tuberculosis depends on aerobic respiration for growth and utilizes an aa3-type cytochrome c oxidase
for terminal electron transfer. Cytochrome cmaturation in bacteria requires covalent attachment of heme to apocytochrome c,
which occurs outside the cytoplasmic membrane. We demonstrate that inM. tuberculosis the thioredoxin-like protein Rv3673c,
which we named CcsX, is required for heme insertion in cytochrome c. Inactivation of CcsX resulted in loss of c-type heme ab-
sorbance, impaired growth and virulence ofM. tuberculosis, and induced cytochrome bd oxidase. This suggests that the bioener-
getically less efficient bd oxidase can compensate for deficient cytochrome c oxidase activity, highlighting the flexibility of the
M. tuberculosis respiratory chain. A spontaneous mutation in the active site of vitamin K epoxide reductase (VKOR) suppressed
phenotypes of the CcsXmutant and abrogated the activity of the disulfide bond-dependent alkaline phosphatase, which shows
that VKOR is the major disulfide bond catalyzing protein in the periplasm ofM. tuberculosis.
IMPORTANCE Mycobacterium tuberculosis requires oxygen for growth; however, the biogenesis of respiratory chain components
in mycobacteria has not been explored. Here, we identified a periplasmic thioredoxin, CcsX, necessary for heme insertion into
cytochrome c. We investigated the consequences of disrupting cytochrome cmaturation (CCM) for growth and survival ofM. tu-
berculosis in vitro and for its pathogenesis. Appearance of a second-site suppressor mutation in the periplasmic disulfide bond
catalyzing protein VKOR indicates the strong selective pressure for a functional cytochrome c oxidase. The observation that
M. tuberculosis is able to partially compensate for defective CCM by upregulation of the cytochrome bd oxidase exposes a func-
tional role of this alternative terminal oxidase under normal aerobic conditions and during pathogenesis. This suggests that tar-
geting both oxidases simultaneously might be required to effectively disrupt respiration inM. tuberculosis.
Received 26 June 2013 Accepted 23 August 2013 Published 17 September 2013
Citation Small JL, Park SW, Kana BD, Ioerger TR, Sacchettini JC, Ehrt S. 2013. Perturbation of cytochrome c maturation reveals adaptability of the respiratory chain in
Mycobacterium tuberculosis.mBio 4(5):e00475-13. doi:10.1128/mBio.00475-13.
Editor Roberto Kolter, Harvard Medical School
Copyright © 2013 Small et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-ShareAlike 3.0 Unported license,
which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
Address correspondence to Sabine Ehrt, sae2004@med.cornell.edu.
Mycobacterium tuberculosis has evolved to survive for decadeswithin host granulomas. An infected host often develops
different types of granulomas, including caseating, fibrotic, and
cavitating lesions, each providing a different environment (1, 2).
Even bacteria within the same lesion may experience different
microenvironments depending on their location within the gran-
uloma (3), and they can exist as multiple subpopulations (4). The
availability of oxygen and nutrients can also differ vastly between
various in vivoniches. It has been shown thatM. tuberculosis, while
residing in cavities, experiences the same oxygen tension as in the
bronchi in the lung (5). However, M. tuberculosis further away
from the cavity surface or localized in noncavitating lesions is
exposed to microaerobic or anaerobic conditions (6). Thus,
throughout the course of infection, even within the same lesion,
M. tuberculosis must adapt its metabolism to survive and persist.
The ability of M. tuberculosis to adapt to multiple environments
can in part be attributed to the modulatory nature of its respira-
tory chain (7, 8). Electrons flow from NADH dehydrogenase and
succinate dehydrogenase complexes into the menaquinone-
menaquinol pool, terminating at either the cytochrome bc1-aa3
oxidoreductase supercomplex or the bd-type menaquinol oxidase
(9–12). Both oxidases use O2 as the terminal electron acceptor.
The cytochrome bc1-aa3 oxidoreductase (CcO) supercomplex
consists of a bc1 di-heme c-type cytochrome reductase, encoded by
qcrCAB, that transfers electrons to the terminal aa3-type Cu-heme
oxidase, encoded by ctaB, ctaC, ctaD, ctaE, and ctaF (8). Cyto-
chromes of the c type are characterized by covalently bound heme,
which is attached via two thioether bonds to the two cysteine
residues in the heme binding motif Cys-Xxx-Xxx-Cys-His (13,
14). This cytochrome cmaturation (CCM) occurs on the outside
the cytoplasmicmembrane (15).M. tuberculosis is predicted to use
a type II CCM system, consisting of four proteins, that is best
characterized in Bacillus subtilis (ResA, ResB, ResC, CcdA) and
Bordetella pertussis (CcsA, CcsB, CcsX, DipZ) (16–19) (see Fig. S1
in the supplemental material). The integral membrane proteins
ResB/CcsA bind heme in the cytoplasm and export it to the extra-
cellular domains of ResC/CcsB, priming it for covalent attach-
ment to apocytochrome c. Thiol reduction is catalyzed by CcdA/
DipZ and the membrane-anchored thioredoxin-like protein,
ResA/CcsX, which reduces the disulfide bond of the Cys-Xxx-
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Xxx-Cys-His motif of apocytochrome c (18–21). In this study, we
identified the ResA/CcsX homolog inM. tuberculosis, encoded by
rv3673c, and investigated the consequences of disrupting cyto-
chrome c biogenesis. We provide evidence that the bioenerget-
ically less efficient cytochrome bd oxidase substitutes for impaired
CcO activity and that loss of CcsX can be compensated for by a
mutation in the disulfide bond-forming protein vitamin K epox-
ide reductase (VKOR).
RESULTS AND DISCUSSION
Identification of a membrane-bound, periplasmic thioredoxin.
We sought to identify the gene encoding M. tuberculosis’s ResA/
CcsX and searched for genes encoding proteins predicted to con-
tain a thioredoxin fold and a single transmembrane helix or to be
localized to the membrane, using the Tuberculist database (22)
and the transmembrane prediction server, TMHMM version 2.0
(23). Of the proteins that matched our criteria, Rv0526 and
Rv3673c were the most likely candidates, with 24% and 33% se-
quence identity to B. subtilis ResA, respectively. Rv3673c is pre-
dicted to contain a single transmembrane helix, and Rv0526 is
predicted to be a secreted lipoprotein. We focused on Rv3673c
because of its membrane-anchoring transmembrane helix and se-
quence similarity to ResA even though rv0526 is located in the
genomic region that contains the other predicted components of
the CCM system. Based on the results of the work presented here,
Rv3673 was named CcsX.
To experimentally confirm that the catalytic domain of CcsX is
located in the periplasm, we created fusions with alkaline phos-
phatase (PhoA) at residues leucine 41, serine 47, and proline 65
and expressed them in Mycobacterium smegmatis (see Fig. S2 in
the supplemental material). PhoA is active only when located in
the oxidizing extracytoplasmic environment and has been used to
determine the topology of membrane proteins (24), including
those in mycobacteria (17, 25). All CcsX-PhoA fusions demon-
strated alkaline phosphatase activity (see Fig. S2B in the supple-
mental material). A plasmid containing PhoA lacking a signal se-
quence served as a negative control, and a plasmid expressing
PhoA fused to the signal sequence of the secreted antigen 85B
served as our positive control (25). Immunoblot analysis ofM. tu-
berculosis expressing Flag-tagged CcsX confirmed its association
with the cell membrane/wall fraction (see Fig. S2C). Taken to-
gether, these data suggest that CcsX is a membrane-associated
protein with an extracellular thioredoxin domain.
CcsX is required for heme insertion in cytochrome c, and
cytochrome bd oxidase can compensate for loss of CcsX. We
created anM. tuberculosismutant strain, theCcsXmutant, in the
background of H37Rv, in which the entire ccsX gene was replaced
with a hygromycin cassette. Deletion of ccsX was confirmed by
Southern blotting (see Fig. S3 in the supplemental material). To
determine the impact of loss of CcsX on CCM, we stained for
proteins with covalently bound heme in membrane fractions of
M. tuberculosis H37Rv wild type (WT), the CcsX mutant, and
the CcsX-comp complemented mutant. Heme staining of WT
membranes revealed five bands at150 kDa, ~80 kDa, ~60 kDa,
~25 kDa, and ~15 kDa (Fig. 1A), and we attempted to identify the
proteins containing covalently bound heme. Liquid
chromatography-tandem mass spectrometry (LC-MS/MS) re-
vealed multiple proteins in each band, at least one of which had a
predicted heme-bindingmotif. Using the LC-MS/MS data, heme-
binding motif predictions, and molecular masses, we assigned a
FIG 1 CcsX is important for cytochrome c maturation. (A) SDS-PAGE and heme staining of membranes from WT M. tuberculosis and the CcsX and
CcsX-comp mutants. Horse heart cytochrome c (C) served as the positive control. (B) Sodium dithionite-reduced minus potassium ferricyanide-oxidized
difference spectra of WT (black line) and CcsX (red line) membranes. Data are means from two independent experiments. (C) Relative mRNA amounts of
respiratory genes in CcsX and CcsX-comp mutants. mRNAs were quantified by quantitative real-time PCR and normalized to sigA and are expressed as
abundance relative to mRNA levels in the WT. Error bars represent standard deviations (SD) from three biological replicates. Student’s t test P values are
indicated (*,P 0.05). (D)Minimal inhibitory concentrations of respiratory chain inhibitors. Log-transformeddrug concentrationswere plotted against growth
normalized to untreated cultures and fit with a nonlinear regression curve.
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heme-bound protein to each band. The band at ~80 kDa corre-
sponds to the catalase-peroxidase KatG (26); the band at~60 kDa
corresponds to SirA, a sulfite reductase with a covalently bound
sirohememoiety (27); and the band at ~25 kDa stems fromQcrC,
the cytochrome c subunit of the bc1 cytochrome c reductase com-
plex (8). Attempts to identify the ~15-kDa protein were unsuc-
cessful, and the 150-kDa band appeared to be an aggregate con-
taining more than one of the heme-containing proteins found in
the lower-molecular-mass bands. Heme staining of membranes
from the CcsX mutant did not reveal bands for SirA or the ~15-
kDa protein, and the band corresponding to QcrC was drastically
reduced in intensity (Fig. 1A). This strongly suggested that CcsX is
important for cytochrome c assembly. Heme binding to KatG was
unaffected by the lack of CcsX, which is not surprising, because
KatG is cytosolic and should thus not depend on the extracyto-
plasmic thioredoxin CcsX for heme attachment. More surprising
was the heme deficiency in SirA, formerly known as NirA, a sulfite
reductase with covalently bound siroheme (27, 28). SirA is a pre-
dicted cytosolic protein and thus unlikely to rely on the extracy-
toplasmic CcsX for heme insertion. Siroheme can, however, be
hijacked and processed into heme in some bacteria and archaea
(29). The defective heme incorporation into QcrC may have re-
sulted in excessive heme export and depletion of intracellular
heme stores, which in turn caused conversion of siroheme to
heme, thereby depleting siroheme in SirA. Alternatively, SirA
might be an extracytoplasmic protein anddirectly rely onCcsX for
siroheme acquisition, as proteomics identified SirA in the mem-
brane/lipid fractions ofM. tuberculosis (30, 31).
To confirm the loss of c-type heme incorporation into QcrC,
reduced minus oxidized difference spectroscopy was used to ana-
lyze the cytochrome content of the aerobically grown WT and
CcsX strains. In WT membranes, major absorbance peaks were
observed at 552, 563, and 600 nm, characteristic of c-, b-, and
a-type cytochromes, respectively (9, 32) (Fig. 1B). In membranes
from the CcsX mutant, the major peak at 552 nm was no longer
visible, indicating a lack of c-type heme. The peak at 563 nm was
unchanged; however, a prominent peak was visible at 631 nm,
which we did not observe in WT membranes. This peak is char-
acteristic of a d-type heme and has been demonstrated to indicate
the presence of the bd oxidase inM. smegmatis following exposure
to microaerobic conditions (O2  1%) but was undetectable
when the bacteria were grown aerobically (9). The bd terminal
oxidase is also induced in M. smegmatis lacking the cytochrome
bc1 oxidase (12) and in M. tuberculosis treated with the cyto-
chrome c-specific inhibitors cyanide and azide or agents affecting
CCM, such as ZnSO4 and dithiothreitol (DTT) (33). Consistent
with the hypothesis that bd oxidase is upregulated in the CcsX
mutant to compensate for the perturbation in CCM,mRNA levels
of genes of the bd oxidase encoding the cyd operon (cydABDC)
were 2- to 3-fold higher in the mutant than in the WT, while
expression levels of qcrC and ctaD were unchanged in the CcsX
mutant (Fig. 1C). Furthermore, theCcsXmutant was hypersus-
ceptible to cyanide and to the proton-translocating FoF1–ATP
synthase inhibitorN,N=-dicyclohexylcarbodiimide (DCCD), sug-
gesting impaired cytochrome c oxidase activity and reduced respi-
ratory energy generation (Fig. 1D). In contrast, the minimal in-
hibitory concentration of thioridazine (TRZ), a phenothiazine
derivative thought to inhibit the type II NADH dehydrogenase
(11, 33, 34), was not different from that of theWT and theCcsX-
comp mutant, suggesting that type II NADH dehydrogenase ac-
tivity is not decreased in the mutant.
Together, these data demonstrate that (i) CcsX is important for
CCM inM. tuberculosis, (ii) Rv0526 is not functionally redundant
with CcsX, and (iii) deletion of CcsX is accompanied by increased
expression of bd oxidase, suggesting that defective CCM resulted
in reduced electron flow through the bc1-aa3 oxidase, which can at
least partially be compensated for by increased bd oxidase activity.
Deficient CCM is associated with increased resistance to
H2O2. Consistent with transposon mutagenesis studies, which
predicted ccsX to be required for optimal growth (35, 36), the
CcsX mutant grew slower than the WT on agar plates and in
liquid medium (Fig. 2A and B). Introducing a copy of ccsX back
onto the mutant chromosome complemented these phenotypes.
Deletion of ResA/CcsX homologs caused increased resistance to
H2O2 treatment in Agrobacterium tumefaciens (37) but hypersus-
ceptibility to H2O2 in Neisseria gonorrhoeae (38). Consistent with
the phenotype in A. tumefaciens, the CcsX mutant was hyperre-
sistant to H2O2 (Fig. 2C), and H2O2 hyperresistance was returned
to WT levels in the complemented mutant, confirming that this
phenotype was due to the loss of CcsX. This response was specific
to H2O2 stress. Exposure to superoxide-generating plumbagin,
acidified sodium nitrite resulting in the generation of reactive ni-
trogen species, and acidification (pH 4.5) did not affect the mu-
tant differently than the WT (see Fig. S4 in the supplemental ma-
terial). To explore the mechanism responsible for H2O2
hyperresistance, we measured expression of genes important for
antioxidant defense in M. tuberculosis (39–42). There was no dif-
ference in katGmRNA or protein abundance between the CcsX
mutant and the WT (Fig. 2D and E), similar to the finding that
H2O2 hyperresistance of the TlpA (CcsX homolog) mutant in
A. tumefaciens was catalase independent (37). mRNA levels of the
thioredoxin genes, trxB1, thiX, and the thioredoxin reductase-
encoding trxB2, were also similar in all strains. In contrast, mRNA
levels of alkyl hydroperoxide reductase (AhpC) were 2.5-fold in-
creased in the CcsX mutant and returned to WT levels in the
complemented strain (Fig. 2D). Consistent with the increased
mRNA levels, protein amounts of AhpC and AhpD, a
thioredoxin-like adaptor protein (43), were also increased in the
CcsX mutant (Fig. 2E). AhpC and AhpD are subunits of M. tu-
berculosis’s peroxidase and peroxynitrite reductase complex and
have been implicated in oxidative and nitrosative stress responses
(39, 42, 43). However, deletion of ahpC inM. tuberculosis resulted
in hypersusceptibility to cumene hydroperoxide but not H2O2
(44). The increased resistance to H2O2 of the CcsX mutant may
also be a consequence of overexpression of the cytochrome bd
oxidase, as E. coli cydmutants are hypersusceptible to H2O2 stress
(45, 46). The cytochrome bd oxidase retains a high affinity for
oxygen (47), and increased expression would result in efficient
scavenging of oxygen radicals produced from the breakdown of
H2O2, leading to increased resistance. Consistent with this is the
observation that cytochrome bd oxidase plays a respiratory pro-
tective role for nitrogen-fixing enzymes which are sensitive to ox-
idative damage (48). It is noteworthy that unlike other terminal
cytochrome oxidases, the cytochrome bd oxidase does not gener-
ate superoxide radicals during catalytic reduction of oxygen,
which serves as a barrier for the formation of excessive endoge-
nous oxidative species (49).
The role of CcsX in pathogenesis. Gene expression analysis
revealed that genes encoding subunits of the cytochrome c oxidase
Cytochrome c Maturation in M. tuberculosis
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and bd oxidase were differentially expressed at different phases of
mouse infection (50). This suggested that cytochrome c oxidase is
most important forM. tuberculosis’s ability to replicate during the
acute phase, while the less-energy-efficient bd oxidase is preferen-
tially required during transition from acute to chronic infection.
The CcsX mutant reached 100-fold-lower CFU than the WT in
mouse lungs at day 21 following low-dose aerosol infections, after
which it maintained a constant titer (Fig. 3A). A similar trend was
observed in spleens, to which the CcsX mutant disseminated
more slowly than the WT and never reached the same bacterial
load (Fig. 3A, right). Growth in lungs and spleens was restored to
WT levels in the complemented mutant (Fig. 3B). Thus, per-
turbed CCM affected replication ofM. tuberculosis in vivo but had
no impact on persistence during chronic mouse infection. These
data suggest that bd oxidase can sufficiently substitute for im-
paired cytochrome c oxidase activity during the chronic phase of
the infectionwhen the bacilli are only slowly or not replicating but
are exposed to the host-adaptive immune response. In addition to
fulfilling a respiratory role in the electron transport chain, cyto-
chrome bd oxidase may protect tubercle bacilli against reactive
oxygen species generated through the adaptive immune response.
In contrast, normal replication early in infection depends on in-
tact CCM and cytochrome c oxidase activity.
AVKORmutation compensates for loss of CcsX.During the
course of these experiments, especially aftermultiple passages, the
CcsX phenotypes became less robust. When plating the mutant
FIG 2 Deletion of CcsX results in impaired growth and increased resistance to H2O2. Growth of WT, CcsX, and CcsX-comp strains on agar plates (A) and
in Sauton’s liquid medium (B). (C) Survival ofM. tuberculosis strains after exposure to hydrogen peroxide. Bacteria were plated and CFUwere determined after
exposure to 4 and 16 mMH2O2 for 4 h. Data are means SD of triplicate cultures and representative of two independent experiments (*, P 0.05, compared
to the WT and compared to the complemented strain). (D) Relative mRNA amounts of potential antioxidant genes in the CcsX and CcsX-comp mutants.
mRNAs were quantified by quantitative real-time PCR and normalized to sigA and are expressed as abundance relative to mRNA levels in the WT. Error bars
represent SD from three biological replicates. Student’s t test P values are indicated (*, P 0.05). (E) Immunoblot analysis of proteins extracts from theWT (lane
1),CcsX (lane 2), andCcsX-comp (lane 3) strains using antisera against AhpC, AhpD, KatG, andDlaT (loading control). Soluble (s) and insoluble (is) protein
fractions were run for the KatG immunoblot.
FIG 3 The CcsX mutant is attenuated in the mouse model of tuberculosis. (A) Growth and survival in mouse lungs (left) and spleens (right) of the WT and
CcsX strains. Data are from 4mice per strain and time point and representative of 2 independent experiments. (B) TheCcsX-comp strain grows like theWT
in mouse lungs and spleens. Data are from 4 mice per strain and time point.
Small et al.
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on 7H10 agar, we noticed a heterogeneous population of colonies,
with some significantly larger than others (see Fig. S5A in the
supplemental material). Both small and big colonies lacked the
ccsX gene, suggesting that the large colonies represented a sup-
pressor mutant (see Fig. S5B and C in the supplemental material).
This putative suppressor strain, the CcsX-S mutant, also grew
significantly faster than the CcsX mutant in liquid medium
(Fig. 4A) and was more susceptible to H2O2 than the CcsX mu-
tant (see Fig. S5D). Whole-genome sequencing revealed a point
mutation in rv2968c/vkor, resulting in an amino acid change in
vitamin K epoxide reductase (VKOR). M. tuberculosis’s VKOR is
functionally similar toDsbB inE. coli (51, 52), which togetherwith
DsbA catalyzes disulfide bond formation in the periplasm (53).
TheCcsX-S mutation caused the proline residue at position 140
to be replaced with a serine (Fig. 4B). This proline lies in the
Cys-Xxx-Xxx-Cys thioredoxin active site and is conserved inmost
thioredoxin family members (54, 55). TMHMMpredicts that this
sequence in VKOR is located in the periplasmic space consistent
with its function. To determine whether the substitution of pro-
line with serine affected the function of VKOR, we expressed the
antigen 85B secretion signal-PhoA fusion protein, whose activity
depends on intramolecular disulfide bond formation (56), in the
WT, the CcsX mutant, and the CcsX-S mutant and measured
alkaline phosphatase activity. PhoA activity was drastically re-
duced in the CcsX-S mutant compared to in the other strains,
suggesting that the point mutation in VKOR-P140S impaired di-
sulfide bond formation in the periplasm of the CcsX-S mutant
(Fig. 4C). Finally we complemented the CcsX-S mutant with
intact VKOR to prove that the suppressor phenotype was caused
by the mutated VKOR. Expression of the native, intact vkor gene
from a tetracycline repressor-controlled promoter in theCcsX-S
mutant resulted in small colonies, while expression of themutated
gene did not affect growth of theCcsX-Smutant (Fig. 4D). Even
in the absence of the inducer anhydrotetracycline (atc), the
CcsX-S mutant transformed with WT VKOR formed smaller
colonies than when transformed with VKOR-P140S, likely be-
cause of leaky expression. The addition of atc exacerbated this
phenotype. Similarly, growth of the CcsX-S mutant expressing
VKOR in atc-containing liquidmediumwas significantly reduced
compared to that of the untransformed control andmimicked the
slow growth of the CcsX mutant (Fig. 4A). In contrast, the
CcsX-S mutant transformed with VKOR-P140S replicated like
the untransformed CcsX-S mutant, and the growth of the WT
was not affected by eitherVKORorVKOR-P140S. Together, these
data demonstrate that the point mutation in VKOR caused the
suppressor phenotype of theCcsX-Smutant.Mutations inDsbA
and DsbB in Rhodobacter capsulatus (57) and B. subtilis (58) have
been demonstrated to compensate for the loss of CcdA and restore
FIG 4 VKOR-P140S can suppress the defects caused by lack of CcsX. (A)Growth ofM. tuberculosis strains in 7H9medium containing 200 ng/ml atc. Expression
of VKOR and VKOR-P140S was from an atc-inducible promoter on an episomal plasmid (66). (B) Amino acid sequence of VKOR. The cysteine residues in the
active site are depicted in pink, and the proline residue, which is mutated to serine in the suppressor strain, is depicted in blue. (C) Alkaline phosphatase activity
inM. tuberculosis strains transformedwith a plasmid that constitutively expresses a fusion of antigen 85B-PhoA. (D)Growth of theCcsX-Smutant transformed
with VKOR-P140S and with wild-type VKPOR on agar plates with and without atc. Expression of VKOR andVKOR-P140S was from an atc-inducible promoter
on an episomal plasmid (66).
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cytochrome c biogenesis. CcdA and its redox partner ResA/CcsX
are required for the periplasmic reduction of the disulfide bond in
apocytochrome c, allowing heme attachment (19, 59). The redox
pair DsbA and DsbB forms the disulfide; thus, mutation in either
of these proteins or the addition of a reducing agent to the me-
dium abrogates the need for CcdA and ResA/CcsX. Similarly, mu-
tation of VKOR suppressed the defect caused by lack of CcsX.
Together, these data not only establish that CcsX is part ofM. tu-
berculosis’s CCM system but also support the hypothesis that
VKOR is the major disulfide bond catalyzing protein inM. tuber-
culosis’s periplasm.
MATERIALS AND METHODS
Strains, media, and molecular biology techniques. M. tuberculosis
(H37Rv) strains were grown inMiddlebrook 7H9 or Sauton’s medium as
described (60). Cultures were grown aerated in roller bottles rotating at
1 rpm or in stationary tissue culture flasks in small volumes (10 ml) and
agitated regularly to ensure aeration. Bacteria were also grown onMiddle-
brook 7H10 or 7H11 agar plates containing 10% oleic acid-albumin-
dextrose-catalase (OADC) supplement (Becton Dickinson) and 0.5%
glycerol. Hygromycin B (50 g/ml), kanamycin (20 g/ml), and strepto-
mycin (20g/ml) were includedwhen selectionwas required. TheCcsX
mutant was constructed using a suicide plasmid (61). Gateway cloning
technology (Invitrogen) was used for clonings (60). For complementa-
tion, ccsX was cloned downstream of the hsp60 promoter into a plasmid
that integrates into the chromosomal attB site and electroporated into the
CcsX mutant. Alkaline phosphatase fusions were created and analyzed
as described (25, 62). RNA isolation and analysis by quantitative real-time
PCR was performed as described (60).
Heme staining and cytochrome spectra. M. tuberculosis lysates were
prepared from mid-log-phase cultures, and membranes were isolated as
described (63). Membranes for heme staining were resuspended in am-
moniumbicarbonate (NH4HCO3; Fisher) by sonicationuntil dissolved. A
total of 80g ofmembrane fractionwas separated on a 4 to 15%Tris-HCl
gradient gel (Bio-Rad). Heme staining was performed as described (64).
LC-MS/MS analysis of excised bands was performed by the Proteomics
Resource Center, Rockefeller University. Membranes for cytochrome
spectra were isolated as described above, except TC buffer (10 mM Tris-
HCl [pH 7.4], 16 mM cholate) was used instead of phosphate-buffered
saline (PBS) for lysis and resuspension of the membrane pellet (9). Re-
duced minus oxidized cytochrome spectra were recorded on a UV-Vis
spectrophotometer (Uvikon XS/XL) at 24°C using a few grains of solid
sodium dithionate as reductant and a few drops of 100 or 200 M potas-
sium ferricyanide as oxidant (9).
Mouse infections. C57BL/6 mice (Jackson Laboratories) were in-
fected using an Inhalation Exposure System (Glas-Col) to deliver ~100 to
200 bacilli per mouse. CFU were quantified by plating serial dilutions of
lung and spleen homogenates from 4 mice per strain per time point on
7H10 agar. Procedures involvingmice were reviewed and approved by the
Institutional Animal Care and Use Committee of Weill Cornell Medical
College.
Whole genome sequencing and analysis. The CcsX strain and a
large-colony suppressor mutant were sequenced using an Illumina Ge-
nome Analyzer IIx. Approximately 5 g of DNA was processed using the
standard Illumina sample preparation protocol (Illumina, Inc.), and the
samples were sequenced in paired-end mode with a read length of 54 bp.
The genome was assembled by mapping reads to the parental H37Rv
genome and calling single-nucleotide polymorphisms and insertions/de-
letions as described (65). The mean depths of coverage (number of reads
covering each site) were 27.9 and 101.2 for the two strains.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at http://mbio.asm.org
/lookup/suppl/doi:10.1128/mBio.00475-13/-/DCSupplemental.
Figure S1, TIF file, 0.9 MB.
Figure S2, TIF file, 1.3 MB.
Figure S3, TIF file, 0.3 MB.
Figure S4, TIF file, 0.4 MB.
Figure S5, TIF file, 1.4 MB.
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